Vagelos Education Center, Room 201, 104 Haven Ave, New York, NY 10032
Dr. Richard Scheller joined 23andMe in 2015 as chief science officer and head of the newly formed therapeutics group. In his role, Dr. Scheller is responsible for building a dedicated research and development team that will use human genetic data as the starting point for identifying new therapies for both common and rare diseases.
Prior to 23andMe, Dr. Scheller retired from a 14-year career at Genentech where he served as executive vice president of research and early development. Dr. Scheller also served on the faculty of Stanford University for 19 years as a professor in the Department of Biological Sciences and the Department of Molecular and Cellular Physiology and was an investigator at the Howard Hughes Medical Institute of Stanford University Medical Center.
In 2013, Dr. Scheller received the Albert Lasker Basic Medical Research Award, often referred to as “America’s Nobels,” for discoveries concerning the molecular machinery and regulatory mechanism that underlie the rapid release of neurotransmitters. He has published more than 280 research studies.
Dr. Scheller is a member of the American Academy of Arts & Sciences and the National Academy of Sciences. He also currently serves on the Board of Trustees for the California Institute of Technology.
Dr. Scheller holds a Bachelor of Science in Biochemistry from University of Wisconsin-Madison and a Ph.D. in Chemistry from the California Institute of Technology. He was a postdoctoral fellow in the Division of Biology at the California Institute of Technology and a postdoctoral fellow in Molecular Neurobiology at Columbia University at the College of Physicians and Surgeons.